Healthcare Services

A key trend shaping the Food Allergy Treatment Market involves the Advancements In Food Allergy Treatment

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Food Allergy Treatment Market Expected To Change Between 2026 And 2030?

The food allergy treatment market size has seen rapid expansion in recent years. It is anticipated to grow from $7.6 billion in 2025 to $8.5 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.8%. This historical growth can be linked to several factors, including an increase in food allergy prevalence, the availability of antihistamines, wider adoption of epinephrine therapy, higher allergy diagnosis rates, and the development of clinical guidelines.

The food allergy treatment market is projected to experience substantial expansion in the coming years. Its size is forecasted to reach $12.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. Factors driving this projected growth include advancements in oral immunotherapy, an increase in biologic treatment options, the rising provision of pediatric allergy care, the need for enduring allergy management solutions, and improved access to healthcare services. Key trends anticipated during this period encompass the increasing acceptance of immunotherapy-driven therapies, a rise in the utilization of epinephrine auto-injectors, an enhanced emphasis on proactive allergy prevention, the broader availability of customized allergy treatment approaches, and heightened public understanding of food allergy conditions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16684&type=smp

What Drivers Are Expected To Influence The Food Allergy Treatment Market During The Forecast Period?

Future expansion of the food allergy treatment market is anticipated, driven by the rise in food adulteration. This practice involves deliberately modifying food items through the incorporation of substandard, hazardous, or unapproved components, or by extracting essential ingredients, typically to boost volume or improve aesthetic appeal, frequently compromising both quality and safety. Several factors contribute to the escalation of food adulteration, including the pursuit of economic benefits, intricate supply chains, insufficient regulatory oversight, advancements in technology, the desire for convenience, global interconnectedness, environmental influences, consumer understanding, profit incentives, and inadequate enforcement of existing rules. A primary driver behind the increase in food adulteration is the rising consumer demand for more affordable goods, which prompts manufacturers to reduce expenses and maximize earnings via unethical methods. This adulteration can elevate the likelihood of allergic responses either by introducing foreign allergens into food items or by undermining the overall safety and reliability of the food supply chain. As an illustration, in 2023, the FDA CORE Network, a U.S.-based government agency, reported that its personnel assessed 69 incidents, addressed 25, and issued 10 public health advisories. This contrasted with 65 incidents, 28 responses, and 11 advisories recorded in 2022. Consequently, the expanding problem of food adulteration is fueling the expansion of the food allergy treatment market.

How Is The Food Allergy Treatment Market Structured Across Different Segments?

The food allergy treatment market covered in this report is segmented –

1) By Drug Type: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anti-Cholinergic, Immuno-Modulators, Epinephrine, Immunotherapy

2) By Route Of Administration: Parenteral, Oral

3) By Allergen Type: Dairy Products, Poultry Product, Tree Nuts, Peanuts, Shellfish, Wheat, Soys, Other Allergens

4) By End-Use: Hospital Pharmacies, Retail Pharmacies, Other End-Uses

Subsegments:

1) By Antihistamines: Oral Antihistamines, Topical Antihistamines, Intranasal Antihistamines

2) By Decongestants: Oral Decongestants, Nasal Decongestants

3) By Corticosteroids: Oral Corticosteroids, Topical Corticosteroids, Intranasal Corticosteroids

4) By Mast Cell Stabilizers: Cromolyn Sodium, Nedocromil

5) By Leukotriene Inhibitors: Montelukast, Zafirlukast

6) By Nasal Anti-Cholinergic: Ipratropium Bromide

7) By Immuno-Modulators: Omalizumab, Dupilumab

8) By Epinephrine: Injectable Epinephrine, Auto-Injectors

9) By Immunotherapy: Oral Immunotherapy (OIT), Sublingual Immunotherapy (SLIT), Epicutaneous Immunotherapy (EPIT)

How Are Trends Impacting The Food Allergy Treatment Market?

Leading firms in the food allergy treatment sector are creating advanced therapies, including monoclonal antibodies, aimed at tackling the fundamental causes of food allergies and offering more potent patient solutions. This type of antibody offers a hopeful method for managing food allergies by specifically targeting immune system elements implicated in allergic responses, thus delivering more precise and impactful treatments for individuals. An example of this is when, in February 2024, the pharmaceutical firm Novartis AG, headquartered in Switzerland, obtained FDA approval for its product Xolair (omalizumab) for the purpose of mitigating IgE-mediated food allergies. Administered subcutaneously, this humanized monoclonal antibody functions by preventing IgE antibodies from binding, consequently lowering the release of chemicals that trigger allergy symptoms. The FDA’s endorsement stems from favorable findings of the Phase III OUtMATCH study, which demonstrated that a considerably greater percentage of food allergy patients, even those as young as 1 year old, who were given Xolair, could consume small quantities of peanut, milk, egg, and cashews without experiencing an allergic reaction, in contrast to the placebo group.

Which Major Players Dominate The Food Allergy Treatment Market?

Major companies operating in the food allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., ALK-Abelló A/S, Stallergenes Greer, Kaleo Inc., HAL Allergy B.V., Vedanta Biosciences Inc., Aimmune Therapeutics, AnaptysBio Inc., Immunomic Therapeutics Inc., Alladapt Immunotherapeutics Inc., Aravax, Prota Therapeutics Pty Ltd., DBV Technologies, Adamis Pharmaceuticals Corporation

Read the full food allergy treatment market report here:

https://www.thebusinessresearchcompany.com/report/food-allergy-treatment-global-market-report

Which Region Is Forecast To Lead The Food Allergy Treatment Market In Terms Of Market Size?

North America was the largest region in the food allergy treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food allergy treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Food Allergy Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16684&type=smp

Browse Through More Reports Similar to the Global Food Allergy Treatment Market 2026, By The Business Research Company

Allergy Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

Peanut Allergy Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/peanut-allergy-treatment-global-market-report

Allergy Immunotherapy Global Market Report

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795